[6] simultaneous blocking of egfr and cyclooxygenase-2 signaling pathway, chemoprevention of hnc
Published 1 year ago • 42 plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
3:12
[21] tumor growth inhibition by simultaneously blocking egfr and cox-2 in a xenograft model
-
3:00
[3] role of cyclooxygenase 2 in tumor progression
-
3:40
[36] egcg inhibit growth and activation of the egfr and human her-2 signaling pathways
-
3:19
[39] egcg effects on growth, egfr signaling, gene expression & chemosensitivity in hnscc cells
-
26:42
monitoring of circulating car t cells
-
47:33
chapter 46 alteration in cellular regulation hematological or neoplastic disorders
-
51:44
flow cytometry in chronic myeloid neoplasms: current recommendations and challenges
-
3:09
[41] egcg decreases vegf production in h&n and breast cancer cells by innhibiting egfr pathways
-
2:17
[49] targeting egfr: integration of novel therapeutics in the management of h&n cancer
-
2:51
[38] egcg blocks her-2/neu and related pathways in h&n, breast cancer cells
-
0:20
why lauren prescott, md, is all in to #endwomenscancer
-
4:26
[stomach] flot vs flot/tp for her2 esophagogastric cancer trial
-
4:02
egfr resisters: an advocacy group - targeted therapies in lung cancer 2023
-
9:59
ac22 - deciphering the role of cancer-associated myeloid cells in resistance to immunotherapy
-
2:01
single cell flourescence micrsoscopy for effercytosis quantification | protocol preview
-
8:03
[lung] afatinib vs cisplatin chemo for egfr lung cancer: survival data from lux-lung trials
-
1:33
luke hoeppner, phd is a 2022 lcrf/egfr resisters research awardee studying egfr tki resistance